Reagent and Library Prep Kit Bundles Available for the MiniSeq System

Order your MiniSeq reagents and library prep kits together for additional savings and convenience. Select item 20005612 and add to your cart.

TruSight Cancer

These expert-defined sequencing research panels target 94 genes and 284 SNPs associated with a predisposition towards various cancers. 続きを読む...
製品の選択

TruSight Cancer – Enrichment Oligos only (4 or 8 Enrichment Reactions)

FC-121-0202

価格
 
 
Illumina Advantage Products

TG TruSight™ Cancer Sequencing Panel

TG-141-1002

アクセサリー製品
どんなアクセサリーが必要ですか?

Illumina® DNA Prep with Enrichment, (S) Tagmentation (96 Samples)

20025524

価格
 
 

Illumina® DNA Prep with Enrichment, (S) Tagmentation (16 Samples)

20025523

価格
 
 

Illumina® DNA Prep, (S) Tagmentation (96 Samples)

20025520

価格
 
 

Illumina® DNA Prep, (S) Tagmentation (16 Samples)

20025519

価格
 
 

IDT® for Illumina® DNA/RNA UD Indexes Set A, Tagmentation (96 Indexes, 96 Samples)

20027213

価格
 
 

TruSight Rapid Capture (1 index, 8 samples, 8 enrichments)

FC-140-1101

価格
 
 

TruSight Rapid Capture (2 indexes, 8 samples, 4 enrichments)

FC-140-1102

価格
 
 

TruSight Rapid Capture (4 indexes, 16 samples, 4 enrichments)

FC-140-1103

価格
 
 

TruSight Rapid Capture (24 indexes, 48 samples, 4 enrichments)

FC-140-1104

価格
 
 

TruSight Rapid Capture (24 indexes, 96 samples, 8 enrichments)

FC-140-1105

価格
 
 

TruSight Rapid Capture (96 indexes, 288 samples, 24 enrichments)

FC-140-1106

価格
 
 

製品のハイライト

Developed in collaboration with cancer genomics experts, these predesigned, ready-to-use oligos enable researchers to sequence a variety of genes and single nucleotide polymorphisms (SNPs) previously linked to cancer predisposition.

  • Targets 94 genes and 284 SNPs associated with a predisposition towards cancer

TruSight Cancer includes genes associated with both common (e.g., breast, colorectal) and rare cancers. In addition, the set includes 284 SNPs found to correlate with cancer through genome-wide association studies (GWAS). Content selection was based on expert curation of the scientific literature and other high-quality resources.

The TruSight Cancer sequencing panel provides custom oligos targeting identified regions of interest. Sufficient product is supplied for four enrichment reactions. TruSight Cancer is compatible with TruSight Rapid Capture.

TruSight Cancer Sample Datasets

6 human reference samples were prepared using the TruSight Cancer sequencing panel. These libraries were sequenced on the MiniSeq System using a high output kit at a 2 x 100 bp read length configuration with dual indexing. The total yield was 5.2 Gb with 95.8% of bases at or above Q30.

Browse the data in BaseSpace Sequence Hub:

* Note that access to this data requires a BaseSpace Sequence Hub login.

Register for BaseSpace Sequence Hub

See All Illumina Cancer Research Panels

This product is available as an Illumina Advantage (TG) product. Illumina Advantage large-scale sequencing products feature lot-specific shipments and testing, extended shelf life, and advanced change notifications for greater laboratory efficiency.

よく一緒に購入される製品

仕様

推奨プロジェクト

装置 推奨サンプル数 リード長
MiniSeq System Samples per run: mid output: 12, high output: 24 (based on > 20x coverage per target) Up to 2 × 150 bp
MiSeq System Samples per run (by reagent kit version): v2: 12, v3: 24 (based on > 20x coverage per target) Up to 2 × 150 bp
NextSeq 550 System Samples per run: mid output: 96, high output: 96 (based on > 20x coverage per target) Up to 2 × 150 bp

製品比較

TruSight Cancer AmpliSeq for Illumina BRCA Panel
Cancer Type Pan-Cancer

Method-Specific Workflow Example

 

Customer Stories

From Arrays to NGS: How Chromosomal Genetics Evolved From Structure to Disease

Researchers from the MGZ Medical Genetic Center are using the Infinium CytoSNP-850K BeadChip and the TruSight Cancer Panel to analyze chromosomal abnormalities.

Read More

製品資料

TruSight Cancer Gene List

product_file | EXCEL < 1 MB

TruSight Cancer

Data Sheet | PDF < 1 MB

Related Products

Note regarding biomarker patents and other patents unique to specific uses of products:
Some genomic variants, including some nucleic acid sequences, and their use in specific applications may be protected by patents. Customers are advised to determine whether they are required to obtain licenses from the party that owns or controls such patents in order to use the product in customer's specific application.